
Sign up to save your podcasts
Or


Some studies make you rethink everything. Others… not so much. This week, it’s a classic Derms on Drugs 6-pack that sorts through what’s actually useful, what’s overhyped, and what might quietly change how you practice. Can Castle testing spare sentinel node biopsies—or not yet? And why U.S. derms (and Patton) disagree with Europe on BP guidance. Plus more!
By Scholars in Medicine4.7
3030 ratings
Some studies make you rethink everything. Others… not so much. This week, it’s a classic Derms on Drugs 6-pack that sorts through what’s actually useful, what’s overhyped, and what might quietly change how you practice. Can Castle testing spare sentinel node biopsies—or not yet? And why U.S. derms (and Patton) disagree with Europe on BP guidance. Plus more!

5,156 Listeners

1,148 Listeners

4,946 Listeners

9,194 Listeners

635 Listeners

145 Listeners

1,888 Listeners

227 Listeners

51 Listeners

1,615 Listeners

3,457 Listeners

8,447 Listeners

422 Listeners

7 Listeners

6 Listeners